Biovail receives U.S. marketing approval

The FDA granted Biovail (BVF; TSE:BVF) marketing approval for its generic version of Adalat CC nifedipine, a hypertension drug marketed by Bayer (DAX:BAYG). Teva Pharmaceuticals (TEVA) will market the...